Publikationen (29) Publikationen, an denen Forscher/innen teilgenommen haben

2012

  1. Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol

    Biology of the Cell, Vol. 104, Núm. 6, pp. 342-351

  2. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294

  3. Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects

    PLoS ONE, Vol. 7, Núm. 5

  4. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

    International Journal of Obesity, Vol. 36, Núm. 11, pp. 1442-1449

  5. Clinical usefulness of a new equation for estimating body fat

    Diabetes Care, Vol. 35, Núm. 2, pp. 383-388

  6. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide y and proopiomelanocortin expression in nondiabetic and diabetic IRS2 -/- mice

    Endocrinology, Vol. 153, Núm. 3, pp. 1129-1140

  7. El carcinoma diferenciado incidental de tiroides es menos prevalente en la enfermedad de Graves que en el bocio multinodular

    Endocrinologia y Nutricion, Vol. 59, Núm. 3, pp. 169-173

  8. El carcinoma diferenciado incidental de tiroides es menos prevalente en la enfermedad de Graves que en el bocio multinodular

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 59, Núm. 3, pp. 169-173

  9. Estudio de la utilidad de la bioimpedancia en la determinación de la grasa visceral y su aplicación en el diagnóstico y tratamiento de la obesidad y sus comorbilidades

    Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 183-184

  10. Executive functions profile in extreme eating/weight conditions: From Anorexia Nervosa to Obesity

    PLoS ONE, Vol. 7, Núm. 8

  11. Gastrointestinal hormones: Uroguanylin-a new gut-derived weapon against obesity?

    Nature Reviews Endocrinology, Vol. 8, Núm. 1, pp. 5-6

  12. Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in spain: The ECOBIM study

    Applied Health Economics and Health Policy, Vol. 10, Núm. 6, pp. 417-430

  13. Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects

    Liver International, Vol. 32, Núm. 6, pp. 951-961

  14. Increased tenascin C and toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 10

  15. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice

    PLoS ONE, Vol. 7, Núm. 1

  16. Lifetime obesity in patients with eating disorders: Increasing prevalence, clinical and personality correlates

    European Eating Disorders Review, Vol. 20, Núm. 3, pp. 250-254

  17. Management of subclinical hyperthyroidism

    International Journal of Endocrinology and Metabolism, Vol. 10, Núm. 2, pp. 490-496

  18. Microchimerism in Graves' disease

    Journal of Thyroid Research, Vol. 2012

  19. Obesity and prostate cancer: Gene expression signature of human periprostatic adipose tissue

    BMC Medicine, Vol. 10

  20. Obesity: Screening for the evident in obesity

    Nature Reviews Endocrinology, Vol. 8, Núm. 10, pp. 570-572